期刊文献+

甲状腺滤泡型乳头状癌临床病理学分析 被引量:2

Clinicopathological analysis of follicular variant of thyroid papillary carcionoma
下载PDF
导出
摘要 目的探讨甲状腺滤泡型乳头状癌的临床病理学特征、诊断与鉴别诊断。方法分析17例甲状腺滤泡型乳头状癌的临床特征、病理学形态、免疫表型,并结合文献复习。结果滤泡型乳头状癌表现为甲状腺结节。17例中部分有完整包膜,部分无包膜或局部有包膜。镜下肿瘤细胞构成滤泡结构,滤泡不规则,不见乳头状结构。细胞核大,轮廓不规则,毛玻璃样核可见,核沟、核内包涵体可见。免疫组化可以表达CKl9、Galectin-3、HBME-1。结论滤泡型乳头状癌是甲状腺乳头状癌中一个亚型,主要构成滤泡结构,不见乳头形成。可被分为包裹亚型与浸润亚型。与甲状腺滤泡性腺瘤及滤泡癌鉴别有一定困难,正确认识其细胞核特征并结合免疫组化表现,可以作出正确诊断。 Objective To investigate the clinicopathological features, diagnosis and differential diagnosis of follicu- lar variant of papillary thyroid carcinoma (FVPTC). Methods The clinical features, histopathological appearance and immunohistochemical findings were analyzed in 17 cases of FVPTC, with review of the relevant literature. Results Nod- ules were seen in 17 cases of FVPTC. Tumors were partially or completely encapsulated in some cases. The others had no capsular. The tumor was composed almost completely of follicles, without papillary growth pattern. Nuclear changes inclu- ding enlargement, nuclear overlapping, nuclear clearing, nuclear grooves and cytoplasmic pseudoinclusions were morpho- logical features in the diagnosis of FVPTC. By immunohistochemistry the tumor cells showed variable staining with CK19, galectin - 3, HBME - 1. Conclusion FVPTC is a common variant of papillary thyroid carcinoma. It is correctly diag- nosed by nuclear characteristics. It is classified into encapsulate FVPTC and infiltrative FVPTC. The main differential di- agnosis is follicular adenoma or follicular carcinoma. Immunohistochemieal staining can assist in separating FVPTC from other follicular tumor.
出处 《徐州医学院学报》 CAS 2012年第7期458-461,共4页 Acta Academiae Medicinae Xuzhou
关键词 甲状腺 滤泡型乳头状癌 临床病理 鉴别诊断 thyroid follicular variant of papillary thyroid carcinoma clinicopathology differential diagnosis
  • 相关文献

参考文献15

  • 1Lloyd RV,Buehler D,Khanafshar E.Papillary thyroid carcinoma variants[J].Head Neck Pathol,2011,5(1):51-56.
  • 2Ghossein R.Encapsulated malignant follicular cell-derived thyroid tumors[J].Endocr Pathol,2010,21(4):212-218.
  • 3Chan JK.Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma[J].Am J Clin Pathol,2002,117(1):16-18.
  • 4Liu J,Singh B,Tallini G,et al.Follicular variant of papillary thyroid carcinoma:a clinicopathologic study of a problematic entity[J].Cancer,2006,107(6):1255-1264.
  • 5Liu Z,Zhou G,Nakamura M,et al.Encapsulated follicular thyroid tumor with equivocal nuclear changes,so-called well-differentiated tumor of uncertain malignant potential:a morphological,immunohistochemical,and molecular appraisal[J].Cancer Sci,2011,102(1):288-294.
  • 6纪小龙,吉米.甲状腺病理诊断[M].北京:人民军医出版社.2011:131-135.
  • 7Ozdemir D,Ersoy R,Cuhaci N,et al.Classical and follicular variant papillary thyroid carcinoma:comparison of clinical,ultrasonographical,cytological,and histopathological features in 444 patients[J].Endocr Pathol,2011,22(2):58-65.
  • 8滕晓东,王丽君,姚洪田,李君,丁伟,严丽萍.细胞角蛋白19、galectin-3、HBME-1在甲状腺病变上的表达及鉴别诊断意义[J].中华病理学杂志,2004,33(3):212-216. 被引量:33
  • 9Adeniran AJ,Zhu Z,Gandhi M,et al.Correlation between genetic alterations and microscopic features,clinical manifestations,and prognostic characteristics of thyroid papillary carcinomas[J].Am J Surg Pathol,2006,30(2):216-222.
  • 10Smith RA,Salajegheh A,Weinstein S,et al.Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant[J].Hum Pathol,2011,42(4):500-506.

二级参考文献20

  • 1Kawachi K, MatsushitaY,Yonezawa S,et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol,2000,31: 428-433.
  • 2Cvejic D,Savin S, Golubovic S,et al.Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression. Histopathology, 2000, 37: 530-535.
  • 3Rigaud G, Missiaglia E, Moore PS, et al. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res, 2001, 61:285-292.
  • 4Figueiredo BC, Stratakis CA, Sandrini R, et al. Comparative genomic hybridization analysis of adrenocortic tumors of childhood. J Clin Endocrinol Metab, 1999, 84:1116-1121.
  • 5Speel EJ, Scheidweiler AF, Zhao J, et al. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9q34 is an early event in insulinomas. Cancer Res, 2001, 61:5186-5192.
  • 6Debelenko LV, Zhuang Z, Emmert-Buck MR, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res, 1997, 57:2238-2243.
  • 7Zhuang Z, Vortmeyer AO, Pack S, et al. Somatic mutations of the MEN 1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res, 1997, 57:4682-4686.
  • 8Hessman O, Lindberg D, Skogseid B, et al. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial malignant tumors of the endocrine pancreas. Cancer Res, 1998, 58:377-379.
  • 9Chen YJ, Vortmeyer AO, Zhuang Z, et al. Loss of heterozygosity of chromosome 1q on gastrinomas: occurrence and prognostic significance. Cancer Res, 2003, 63:817-823.
  • 10Sidhu S, Marsh DJ, Theodosopoulos G, et al. Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab, 2002, 87:3467-3474.

共引文献55

同被引文献12

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部